Live
- Three persons admitted to hospital for diarrhea treatment
- First Star Outside Milky Way Captured: WOH G64 is 2,000 Times Larger Than the Sun
- Sikkim govt to constitute state Niti Ayog: CM Tamang
- CBI books Rajasthan narcotics inspector for Rs 3 lakh bribe
- Rajasthan bypolls: A tough contest between BJP and Congress
- Albania joins SEPA, paving way for EU integration
- Japanese government approves 250-billion USD economic package to ease price pain
- Six pharma companies to set up their units in Telangana
- The Unstable Events of a 17-Wicket Day in Perth: India vs Australia
- Dutch FM's Israel trip cancelled after Netanyahu's arrest warrant
Protein research opens potential treatment of Alzheimers
In a potential breakthrough in treatment of Alzheimer\'s disease, researchers have discovered that a protein can reverse the devastating disease projected to affect nearly 65 million people globally by 2030. The study was led by scientists at the University of Glasgow (UG) and the Hong Kong University of Science and Technology (HKUST).
London: In a potential breakthrough in treatment of Alzheimer's disease, researchers have discovered that a protein can reverse the devastating disease projected to affect nearly 65 million people globally by 2030. The study was led by scientists at the University of Glasgow (UG) and the Hong Kong University of Science and Technology (HKUST).
The research, published in Proceedings of the National Academy of Sciences USA (PNAS), was co-led by Professor Eddy Liew from the UG's Institute of Infection, Immunity and Inflammation and Professor Nancy Ip of HKUST.
The study has discovered that a protein called IL-33 can reverse Alzheimer's disease like pathology and cognitive decline in mice. Alzheimer's disease is a devastating condition with no known effective treatment.
It is the most common cause of dementia, affecting around 850,000 people in the UK, mainly over the age of 65. It affects 1/14 people in this age group and is increasing with the ageing population.
Globally, 65 million people are projected to develop Alzheimer's by 2030. Professor Eddy Liew, Fellow of the Royal Society, who co- directed the research said, "Alzheimer's disease currently has an urgent unmet clinical need.
